Rafferty Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Rafferty Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-38,099	Closed	-$2M	–	1077
2020 Q3	$2M	Buy	38,099 +7,333	+24%	+$304K	0.02%	417
2020 Q2	$1.02M	Buy	+30,766	New	+$980K	0.01%	536
2020 Q1	–	Sell	-43,392	Closed	-$856K	–	884
2019 Q4	$856K	Sell	43,392 -32,454	-43%	-$519K	0.01%	583
2019 Q3	$983K	Sell	75,846 -9,767	-11%	-$118K	0.02%	547
2019 Q2	$1.07M	Buy	85,613 +2,279	+3%	+$30.3K	0.02%	556
2019 Q1	$1.21M	Buy	+83,334	New	+$1.06M	0.02%	512

Rafferty Asset Management's MNTA Position: Q4 2020 in Review

Rafferty Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 38,099 shares — an estimated $2M sold.

Rafferty Asset Management first reported a position in MNTA in Q1 2019 and held it in 6 quarters. The position peaked at $2M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Rafferty Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Rafferty Asset Management sold 38,099 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2M.
Rafferty Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2019 and held it in 6 quarters.
Rafferty Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $2M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Rafferty Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.